Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Gordon Michael Adam. Director active across 2 companies, notably Lucid Diagnostics Inc.. Cumulatively, 5 filings have been recorded. Activity tracked since 7 May 2024. The latest transaction was filed on 2 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations
Gordon Michael Adam has 4 filings in total. In the 4 sampled filings, dated from 2024-05-08 to 2026-04-03, the transaction nature is Attribution and the buy and sell amounts are EUR 0. He is General Counsel at PAVmed Inc. and General Counsel and Secretary at Lucid Diagnostics Inc.